FUNDAMENTAL PARADIGMS IN CLINICAL PHARMACOLOGY: A DUAL PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC EVALUATION OF POLYPHARMACY IN CHRONIC METABOLIC DISORDERS. Res. Jou. Ana.Inv. 2026;7(5):1-8. doi:10.17605/